Patients carrying the GC+CC genotype of the ALDH3A1 gene also demonstrated a significant increase in thrombocytopenia grades after the first, second, and third cycles of the AC regimen (p-value < 0.05). The gene discussed is ALDH3A1; the disease is Thrombocytopenia.